IHiHuman Inc.

NYSE ihuman.com


$ 1.90 $ 0.08 (4.4 %)    

Thursday, 16-May-2024 15:16:23 EDT
QQQ $ 452.32 $ -0.40 (-0.09 %)
DIA $ 398.96 $ -0.15 (-0.04 %)
SPY $ 528.99 $ 0.06 (0.01 %)
TLT $ 91.79 $ 0.17 (0.19 %)
GLD $ 223.41 $ 1.17 (0.53 %)
$ 1.9
$ 1.88
$ 0.00 x 0
$ 0.00 x 0
$ 1.88 - $ 1.91
$ 1.68 - $ 3.68
36,836
na
520.15M
$ 0.42
$ 20.41
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

 ihuman-q4-adj-epads-009-down-from-011-yoy-sales-3527m-down-from-3780m-yoy

iHuman (NYSE:IH) reported quarterly adjsuted earnings of $0.09 per share. This is a 18.18 percent decrease over earnings of $0....

 ihuman-average-total-maus-q3-were-2536m-up-by-229-yoy

Average total MAUs for the quarter were 25.36 million, an increase of 22.9% year-over-year from 20.63 million in the same perio...

 ihuman-q3-eps-014-up-from-011-yoy-sales-3580m-up-from-3536m-yoy

iHuman (NYSE:IH) reported quarterly earnings of $0.14 per share. This is a 27.27 percent increase over earnings of $0.11 per sh...

 ihuman-inc-average-total-maus-q2-were-2033m-up-by-117-yoy

Average total MAUs for the quarter were 20.33 million, an increase of 11.7% year-over-year from 18.20 million in the same perio...

 ihuman-q2-adj-epads-011-up-from-007-yoy-sales-3323m-down-from-3443m-yoy

iHuman (NYSE:IH) reported quarterly earnings of $0.11 per share. This is a 57.14 percent increase over earnings of $0.07 per sh...

 earnings-scheduled-for-june-21-2023

Companies Reporting Before The Bell • iHuman (NYSE:IH) is projected to report earnings for its first quarter.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION